Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Innere Klinik (Tumorforschung)
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients : Results of an Explorative Randomized Controlled TrialIn: Integrative Cancer Therapies Jg. 22 (2023)ISSN: 1552-695X; 1534-7354Online Volltext: dx.doi.org/ (Open Access)
-
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers : Results of the prospective multicenter German KeSBa projectIn: Journal of Cancer Research and Clinical Oncology (2023) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Development of an AI-supported exercise therapy for advanced cancer patientsIn: Current Directions in Biomedical Engineering Jg. 8 (2022) Nr. 2, S. 169 - 172ISSN: 2364-5504Online Volltext: dx.doi.org/ (Open Access)
-
Entwicklung einer KI-gestützten Bewegungstherapie bei onkologischen Palliativpatienten : Eine PilotstudieIn: Bewegungstherapie und Gesundheitssport B&G Jg. 38 (2022) Nr. 05, S. 208 - 215ISSN: 1613-0863; 1613-3269Online Volltext: dx.doi.org/
-
Palliative care outpatients in a German comprehensive cancer center : identifying indicators for early and late referralIn: BMC Palliative Care Jg. 21 (2022) Nr. 1,ISSN: 1472-684XOnline Volltext: dx.doi.org/ (Open Access)
-
The OUTREACH study : oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospiceIn: Journal of Cancer Research and Clinical Oncology (2022) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Web-based mindfulness and skills-based distress reduction for patients with cancer : study protocol of the multicentre, randomised, controlled confirmatory intervention trial ReductIn: BMJ Open Jg. 12 (2022) Nr. 6,ISSN: 2044-6055Online Volltext: dx.doi.org/ (Open Access)
-
A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancerIn: Cancers Jg. 13 (2021) Nr. 17,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative studyIn: Supportive Care in Cancer Jg. 29 (2021) Nr. 9, S. 5127 - 5137ISSN: 1433-7339; 0941-4355Online Volltext: dx.doi.org/ (Open Access)
-
In ReplyIn: Deutsches Ärzteblatt international Jg. 118 (2021) Nr. 44, S. 758ISSN: 1866-0452Online Volltext: dx.doi.org/ (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine Jg. 13 (2021) Nr. 1,ISSN: 1756-994XOnline Volltext: dx.doi.org/ (Open Access)
-
Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairmentIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 5,ISSN: 1660-4601; 1661-7827Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
PARPACT – Paramedic Palliative Care Test : Validierung eines Tests für palliatives Wissen und Selbstwirksamkeitserwartung bei Mitarbeiter*innen im RettungswesenIn: Der Schmerz (2021) in pressISSN: 1432-2129; 0932-433XOnline Volltext: dx.doi.org/ (Open Access)
-
Screening for Palliative Care Needs : Pilot Data From German Comprehensive Cancer CentersIn: JCO Oncology Practice Jg. 17 (2021) Nr. 10, S. e1584 - e1591ISSN: 2688-1535; 2688-1527Online Volltext: dx.doi.org/
-
Symptoms during outpatient cancer treatment and options for their managementIn: Deutsches Ärzteblatt international Jg. 118 (2021) S. 291 - 297ISSN: 1866-0452Online Volltext: dx.doi.org/ (Open Access)
-
Zusammenarbeit von Intensivmedizin und Palliativmedizin : Eine Bestandsaufnahme an den deutschen onkologischen SpitzenzentrenIn: Medizinische Klinik - Intensivmedizin und Notfallmedizin Jg. 116 (2021) Nr. 7, S. 586 - 594ISSN: 2193-6226; 2193-6218Online Volltext: dx.doi.org/ (Open Access)
-
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsIn: Oncology Research and Treatment Jg. 44 (2021) Nr. 7-8, S. 400 - 407ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access)
-
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expressionIn: Cancer Medicine Jg. 9 (2020) Nr. 13, S. 4527 - 4539ISSN: 2045-7634Online Volltext: dx.doi.org/ (Open Access)
-
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological PatientsIn: Frontiers in Psychology Jg. 11 (2020) S. 1984ISSN: 1664-1078Online Volltext: dx.doi.org/ (Open Access)
-
Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patientsIn: BMC Palliative Care Jg. 19 (2020) Nr. 1, S. 43ISSN: 1472-684XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer centerIn: Journal of Cancer Research and Clinical Oncology (2020)ISSN: 1432-1335; 0171-5216Online Volltext: dx.doi.org/ (Open Access)
-
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsIn: Cellular and Molecular Life Sciences - CMLS Jg. 77 (2020) Nr. 3, S. 497 - 509ISSN: 1420-682X; 1420-9071Online Volltext: dx.doi.org/ (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research Jg. 80 (2020) Nr. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers Jg. 11 (2019) Nr. 2, S. 238ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Integration of palliative care into the comprehensive cancer center of Germany - Consultation hours and fellowship rotations of the specialized palliative careIn: TumorDiagnostik & Therapie Jg. 40 (2019) Nr. 5, S. 293 - 299ISSN: 1439-1279; 0722-219XOnline Volltext: dx.doi.org/
-
Knowledge and Self-Efficacy Assessment of Residents and Fellows Following Palliative Care Unit Rotation : A Pilot StudyIn: American Journal of Hospice & Palliative Medicine Jg. 36 (2019) Nr. 6, S. 492 - 499ISSN: 1938-2715; 1049-9091; 0749-1565Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Palliativdienste in den deutschen onkologischen SpitzenzentrenIn: Deutsche Medizinische Wochenschrift - DMW Jg. 144 (2019) Nr. 23, S. E153 - E159ISSN: 1439-4413; 0012-0472; 1437-5982Online Volltext: dx.doi.org/ (Open Access)
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands – ambulante Sprechstunden und Rotationsprogramme der spezialisierten PalliativmedizinIn: Deutsche Medizinische Wochenschrift - DMW Jg. 143 (2018) Nr. 17, S. e139 - e145ISSN: 1439-4413; 0012-0472; 1437-5982Online Volltext: dx.doi.org/
-
Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie : eine retrospektive Analyse eines Comprehensive Cancer CenterIn: Der Onkologe Jg. 24 (2018) Nr. 1, S. 69 - 75ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer centerIn: Supportive Care in Cancer Jg. 26 (2018) Nr. 10, S. 3641 - 3647ISSN: 1433-7339; 0941-4355Online Volltext: dx.doi.org/
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry Jg. 64 (2018) Nr. 7, S. 1054 - 1062ISSN: 0009-9147; 1530-8561Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports Jg. 15 (2017) Nr. 5, S. 2957 - 2968ISSN: 1791-2997; 1791-3004Online Volltext: dx.doi.org/ (Open Access)
-
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancerIn: Clinical Chemistry Jg. 63 (2017) Nr. 10, S. 1585 - 1593ISSN: 1530-8561; 0009-9147Online Volltext: dx.doi.org/
-
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer : efficacy, safety and prognostic parametersIn: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 10, S. 2131 - 2141ISSN: 0171-5216; 0171-5216Online Volltext: dx.doi.org/
-
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: BMC Cancer Jg. 16 (2016) Nr. 1, S. 522ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatmentIn: OncoTarget Jg. 7 (2016) Nr. 27, S. 41677 - 41690ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Gene expression signatures in circulating tumor cells are prognostic for metastatic lesions in breast cancer patients and correlate with response to therapyIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 502ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 141 (2015) Nr. 1, S. 87 - 92ISSN: 0171-5216; 1432-1335Online Volltext: dx.doi.org/
-
Expression profiling of circulating tumor cells : A prognostic and predictive biomarker in metastatic breast cancerIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patientsIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. e22032ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer Jg. 49 (2013) Nr. 15, S. 3076 - 3082ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88ISSN: 1573-7217; 0167-6806Online Volltext: dx.doi.org/
-
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerIn: Oncology Reports Jg. 30 (2013) Nr. 1, S. 441 - 447ISSN: 1021-335XOnline Volltext: dx.doi.org/
-
Aktuelle Therapiestrategien beim metastasierten MammakarzinomIn: TumorDiagnostik & Therapie Jg. 33 (2012) Nr. 2, S. 86 - 89ISSN: 1439-1279; 0722-219XOnline Volltext: dx.doi.org/
-
Trends in survival of patients with metastatic breast cancerIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 187ISSN: 0378-584X; 1423-0240
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204ISSN: 0378-584X; 1423-0240
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research Jg. 71 (2011) Nr. Suppl. 24,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patientsIn: Gynecologic Oncology Jg. 122 (2011) Nr. 2, S. 356 - 360ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Abstract PD02-04: Molecular Profiling of Circulating Tumor Cells in Blood of Metastatic Breast Cancer Patients Indicates Therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem Cell MetabolismIn: Cancer Research Jg. 70 (2010) Nr. 24, S. PD02 - 04ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptorIn: Journal of Clinical Oncology Jg. 22 (2004) Nr. 1, S. 175 - 184ISSN: 0732-183XOnline Volltext: dx.doi.org/
-
Evaluation of an interventional prospective study with oncological training and exercise therapy (OTT) in a health insurance care contract
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 280ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Influence of external and self-assessment in symptom burden of cancer patients in a palliative care outpatient clinic of a Comprehensive Cancer Center
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 92ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Outcome evaluation of postgraduate training in palliative medicine
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 27ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 121 - 122ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Clinical Trials Jg. 80 (2020) Nr. Suppl. 16, S. 5366ISSN: 0008-5472; 1538-7445Online Volltext: dx.doi.org/ -
Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 210ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Barriers and motivation of physical activitiy (PA) in patients with cancer related fatigue (CRF)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 165ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatmentIn: Cancer Research Jg. 79 (2018) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19ISSN: 2296-5262Online Volltext: dx.doi.org/ (Open Access)
-
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research Jg. 73 (2013) S. PD6 - 3ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 212ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/